Trial Profile
A Phase III, Multicenter, Randomized, Double-blind, Placebo-Controlled, Safety Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus Treated With Dutogliptin.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 22 Mar 2012
Price :
$35
*
At a glance
- Drugs Dutogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Forest Laboratories
- 14 Jun 2011 New trial record